Copyright
©The Author(s) 2017.
World J Cardiol. Aug 26, 2017; 9(8): 673-684
Published online Aug 26, 2017. doi: 10.4330/wjc.v9.i8.673
Published online Aug 26, 2017. doi: 10.4330/wjc.v9.i8.673
Figure 5 Expression of interleukin-20Rα/β and activation of signal transducer and activator of transcription 3 in male and female double transgenic mice.
A: IL-20Rα and IL-20Rβ expression were similar in male and female DTG mice; B: Similarly, the ratio of IL-20Rα/β did not differ between sexes; C: STAT3 activation did not differ between male and female DTG mice; D: Representative immunoblotting images. Expression of IL-20R was assessed by qRT-PCR and expressed and ΔCt calculated relative to 18S. The ratio of IL-20Rα/β was calculated as a fold change of α-β within each sex. Activation of STAT3 was assessed by immunoblotting of phospho STAT3/total STAT3. Both male and female mice were run on the same gel, and non-essential lanes were cropped for generation of the representative image. Data are expressed as mean ± SEM; n = 4-7 mice per group. STAT3: Signal transducer and activator of transcription 3; DTG: Double transgenic.
- Citation: Bruns DR, Ghincea AR, Ghincea CV, Azuma YT, Watson PA, Autieri MV, Walker LA. Interleukin-19 is cardioprotective in dominant negative cyclic adenosine monophosphate response-element binding protein-mediated heart failure in a sex-specific manner. World J Cardiol 2017; 9(8): 673-684
- URL: https://www.wjgnet.com/1949-8462/full/v9/i8/673.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i8.673